true, as expected. But...the sky isn't falling either! They are in a great position for a lot of tax free profits. Cash building to nearly $26M was a very positive sign. With Watson paying for all R&D in any next Gen products, CBRX sits in an advantageous position for many years. Crinone will continue to grow overseas in a big way and is the ace in the hole around the Prochieve mess in the US. The question is will they ever hit the homerun!